Mumbai--Intas Pharmaceuticals Ltd said on Monday it has filed a draft prospectus with the Indian capital market regulator for an initial share sale. 

The company plans to raise up to 4.25 billion rupees ($94.7 million) by selling new shares, while Mozart Ltd wants to sell about 5.8 million shares it holds in Intas, it said in a press statement. 

Kotak Mahindra Capital Co. and Morgan Stanley India Co. Pvt Ltd. are the book running lead managers of the issue, it added.